Regulatory Briefs: Reclassification Of Scleral Plug; Radiation Dose Standards
This article was originally published in The Gray Sheet
Executive Summary
FDA reclassifies scleral plug, a pre-amendment ophthalmic device, from class III to class II with special controls. The Medical Imaging & Technology Alliance publishes its fourth standard to optimize radiation dose exposure.
You may also be interested in...
Regulatory News In Brief
New guidance, rules and more from FDA and Congress.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.